KYTX·501976104·US·equity·Healthcare - Biotechnology-13D/G
KYTX (KYVERNA THERAPEUTICS INC) is held by 62 institutional investors as of Q1 2026. Largest holders: BALYASNY ASSET MANAGEMENT L.P. ($9.7M), MILLENNIUM MANAGEMENT LLC ($8.7M), MORGAN STANLEY ($8.4M). Net institutional sentiment: Mixed.
See how KYTX's score breaks down across 4 SEC sources
Showing 1-20 of 66
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer